EFS12- Book of abstracts - Contact
EFS12- Book of abstracts - Contact
EFS12- Book of abstracts - Contact
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SESSION 4: GENETICS OF HOSTS – PLANT RESISTANCE TO FUSARIUM,<br />
VARIETY DEVELOPMENT<br />
P100 - S-Methyl-DON: Chemical synthesis and toxicity<br />
<strong>of</strong> a novel DON metabolite<br />
T. Weigl-Pollack 2 , G. Wiesenberger 1 , P. Fruhmann 2 , H. Mikula 2 , C. Hametner 2 ,<br />
B. Kluger 1 , R. Schuhmacher 1 , R. Krska 1 , J. Fröhlich 2 , G. Adam 1<br />
1 University <strong>of</strong> Natural Resources and Life Sciences, Vienna (BOKU), Konrad Lorenz Str, 20 - 24, A<br />
3430 Tulln Austria; 2 University <strong>of</strong> Technology, Institute <strong>of</strong> Applied Synthetic Chemistry, A-1060 Vienna,<br />
Austria<br />
E-mail: gerlinde.wiesenberger@boku.ac.at<br />
Previously performed microarray studies <strong>of</strong> deoxynivalenol (DON) treated barley<br />
revealed a strong up-regulation <strong>of</strong> cysteine biosynthesis genes, providing the first<br />
evidence for glutathione-mediated detoxification <strong>of</strong> DON (Gardiner et al., 2010).<br />
S-Methyl-DON (SMD) is a plant metabolite <strong>of</strong> DON first described to occur in<br />
Fusarium infected barley and wheat by Kushalappa et al. in 2010. Our hypothesis<br />
is that SMD is derived from a DON-cysteine adduct, which is again generated by<br />
processing <strong>of</strong> a DON-glutathione adduct. The in planta occurrence <strong>of</strong> a DONglutathione<br />
conjugate, and <strong>of</strong> DON-S-Cys-Gly and DON-S-Cys after DON<br />
treatment has recently been demonstrated (Kluger et al., 2012). Presumably SMD<br />
is generated by activity <strong>of</strong> a cysteine-S-conjugate beta-lyase and subsequent<br />
methylation <strong>of</strong> DON-SH. The aim <strong>of</strong> this study was to synthesize SMD for<br />
structure determination, as reference substance for quantification, and for toxicity<br />
testing. SMD was obtained by reaction <strong>of</strong> DON with iodomethane and thiourea in<br />
the presence <strong>of</strong> sodium carbonate and wet polyethylene glycol. 2D-NMR was<br />
used to elucidate the structure <strong>of</strong> the purified main product, which revealed the<br />
desired addition <strong>of</strong> a methylthio group to the double bond <strong>of</strong> DON (C10), but also<br />
formation <strong>of</strong> an intramolecular hemiketal (C15-OH reacting with the C8-keto<br />
group). The SMD concentration required for 50% growth inhibition <strong>of</strong> a sensitive<br />
yeast bioindicator strain was about 9-fold higher than for DON. Tests for the<br />
inhibition <strong>of</strong> protein synthesis <strong>of</strong> wheat ribosomes (using a wheat germ in vitro<br />
translation system) showed that SMD is at least 12-fold less toxic than DON. This<br />
strongly indicates that addition <strong>of</strong> the much larger cysteine and glutathione<br />
substituents should also lead to detoxification due to steric hindrance preventing<br />
interaction <strong>of</strong> the toxin-conjugate with the ribosomal target.<br />
Keywords: glutathione, conjugate, processing, detoxification<br />
193